Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIORISE: Biomarkers for Radiation Sensitivity in Breast Cancer
NCT03252717Active, not recruiting
- Sponsor
- Institut du Cancer de Montpellier
- Start
- Aug 2014
- Primary completion
- Aug 2017
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Institut du Cancer de Montpellier. Primary endpoint: Dosage of a panel of five proteins (AK2, IDH2, ANX1, APEX1, HSC70) at 5 years. Started Aug 2014; status: active, not recruiting.
Beyond the preview
Go deeper on NCT03252717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03252717.